Table 1.
Bacterial strains used in this study.
| Bacterial strain | Characteristics (source, antibiotic resistance) |
|---|---|
| Micrococcus luteus B-1314 | Laboratory strain (VKM collection) |
| Bacillus subtilis B-886 | Laboratory strain (VKM collection) |
| Enterococcus faecalis ATCC 29212 | Laboratory strain (ATCC collection) |
| Staphylococcus aureus ATCC 29213 | Laboratory strain (ATCC collection) |
| Staphylococcus aureus 209P | Laboratory strain (ATCC collection) |
| Escherichia coli DH10B | Cloning strain (Invitrogen) |
| Escherichia coli BL21 (DE3) | Expression strain (Novagen) |
| Escherichia coli BL21 Star (DE3) | Expression strain (Novagen) |
| Escherichia coli ML-35p | Laboratory strain (ATCC collection) |
| Escherichia coli C600 | Laboratory strain (ATCC collection) |
| Escherichia coli (XDR CI 1057) | Extensively drug resistant clinical isolate (urine, urinary tract infection; ESBL+) |
| Escherichia coli (CI 214) | Clinical isolate (urine, acute pyelonephritis) |
| Klebsiella pneumoniae (CI 287) | Clinical isolate∗ |
| Klebsiella pneumoniae (XDR CI 1056) | Extensively drug resistant clinical isolate (urine, urinary tract infection; ESBL+) |
| Enterobacter cloacae (XDR CI 4172) | Extensively drug resistant clinical isolate∗ (MBL+) |
| Acinetobacter baumannii (XDR CI 2675) | Extensively drug resistant clinical isolate∗ (MBL+) |
| Pseudomonas aeruginosa PAO1 | Laboratory strain (ATCC collection) |
| Pseudomonas aeruginosa (XDR CI 1049) | Extensively drug resistant clinical isolate (urine, kidney stone disease; MBL+) |
| Proteus mirabilis (XDR CI 3423) | Extensively drug resistant clinical isolate∗ (MBL+) |
CI, clinical isolate; ∗, no data available on strain source; XDR, extensively drug resistant strain; ESBL+, extended spectrum beta-lactamase producing strain; MBL+, metallo-beta-lactamase producing strain.